Enrica Abrigo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Enrica Abrigo has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Federica Chiale
Neonatal Pathology and Neonatal Intensive Care Unit, Sant’Anna Hospital, City of Health and Science University Hospital of Turin, University of Turin, 10126 Turin, Italy
1 shared publication Gianpaolo Di Rosa
Regina Margherita Children's Hospital, Department of Radiology, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy
1 shared publicationIsabella Morra
Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Department of Pathology, Turin, Italy
1 shared publicationLicia Peruzzi
Regina Margherita Children's Hospital, Nephrology Dialysis and Transplantation Unit, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy
1 shared publicationLuca Lonati
Regina Margherita Children's Hospital, Division of Pediatric General Surgery, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy
1 shared publicationSilvia Einaudi
Regina Margherita Children's Hospital, Pediatric Endocrinology, AOU Citta della Salute e della Scienza, University of Turin, Turin, Italy
1 shared publication
Latest Publications
- 6 September 2019
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 32 (10) , 1193-1197
Severe arterial hypertension and hyperandrogenism in a boy: a rare case of catecholamine- and β-HCG-secreting pheochromocytoma
Background: Pheochromocytomas (PCCs) and paragangliomas (PGLs) are known to physicians as the “great mimickers” because of their variable presentation, especially in the pediatric population. Rarely, they co-secrete other hormones. Case presentation: An 11-year-old boy presented with severe hypertension (HTN) with cardiac target organ damage. Signs of genital and cutaneous androgenization were observed, but the gonadal volume was prepubertal (2 mL). Urine normetanephrine and norepinephrine levels were elevated. Increased beta-human chorionic gonadotropin (β-HCG) and pubertal testosterone values with suppressed values of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) suggested an androgenization secondary to HCG hyperproduction. Imaging revealed a right adrenal mass, suggestive for PCC. Histopathology confirmed a PCC with positive staining for β-HCG. Postoperative resolution of symptoms of β-HCG and catecholamine excess and normalization of hormonal levels confirmed the diagnosis. Conclusions: Ectopic hormone secretion from PCC is possible, even if rare. Signs and symptoms attributable to ectopic hormones should be investigated in PCC patients. To date, this is the first case of a β-HCG-secreting PCC.
- 6 September 2019
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 32 (10) , 1193-1197
Severe arterial hypertension and hyperandrogenism in a boy: a rare case of catecholamine- and β-HCG-secreting pheochromocytoma
Background: Pheochromocytomas (PCCs) and paragangliomas (PGLs) are known to physicians as the “great mimickers” because of their variable presentation, especially in the pediatric population. Rarely, they co-secrete other hormones. Case presentation: An 11-year-old boy presented with severe hypertension (HTN) with cardiac target organ damage. Signs of genital and cutaneous androgenization were observed, but the gonadal volume was prepubertal (2 mL). Urine normetanephrine and norepinephrine levels were elevated. Increased beta-human chorionic gonadotropin (β-HCG) and pubertal testosterone values with suppressed values of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) suggested an androgenization secondary to HCG hyperproduction. Imaging revealed a right adrenal mass, suggestive for PCC. Histopathology confirmed a PCC with positive staining for β-HCG. Postoperative resolution of symptoms of β-HCG and catecholamine excess and normalization of hormonal levels confirmed the diagnosis. Conclusions: Ectopic hormone secretion from PCC is possible, even if rare. Signs and symptoms attributable to ectopic hormones should be investigated in PCC patients. To date, this is the first case of a β-HCG-secreting PCC.